Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diala Abd-Rabbo

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|March 10, 2012
Allelic transcripts dosage effect in morphologically normal ovarian cells from heterozygous carriers of a BRCA1/2 French Canadian founder mutationDiala Abd-Rabbo, Christine Abaji, Guillaume B Cardin, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
Molecular, metabolic and functional CD4 T cell paralysis impedes tumor controlMengdi Guo, Diala Abd-Rabbo, Bruna Bertol, et al.
Cell Reports|August 31, 2023
Molecular, metabolic, and functional CD4 T cell paralysis in the lymph node impedes tumor controlMengdi Guo, Diala Abd-Rabbo, Bruna C Bertol, et al.
Nature Immunology|November 19, 2021
Dynamic CD4<sup>+</sup> T cell heterogeneity defines subset-specific suppression and PD-L1-blockade-driven functional restoration in chronic infectionLaura M Snell, Wenxi Xu, Diala Abd-Rabbo, et al.
Nature Communications|November 21, 2025
Topoisomerase IIb binding delineates localized mutational processes and driver mutations in cancer genomesLiis Uusküla-Reimand, Christian A Lee, Robin H Oh, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2024
A Unified Atlas of T cell GlycophysiologyFauzia N Izzati, Hani Choksi, Paolo Giuliana, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2026
Sequential infection reprograms the immune landscape to shape future responsesMengdi Guo, Yanis Hichem Bouzaher, Diala Abd-Rabbo, et al.
Immunity|November 12, 2022
The transcription factor IRF2 drives interferon-mediated CD8<sup>+</sup> T cell exhaustion to restrict anti-tumor immunitySabelo Lukhele, Diala Abd Rabbo, Mengdi Guo, et al.
Cell Reports|July 3, 2025
Presentation of immunoregulatory sialoglycans on T cells is divergent between mice and humansFauzia N Izzati, Hani Choksi, Paolo Giuliana, et al.
Molecular Cell|January 19, 2020
Candidate Cancer Driver Mutations in Distal Regulatory Elements and Long-Range Chromatin Interaction NetworksHelen Zhu, Liis Uusküla-Reimand, Keren Isaev, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Cancer Prevention Research (Philadelphia, Pa.)|March 10, 2012
Allelic transcripts dosage effect in morphologically normal ovarian cells from heterozygous carriers of a BRCA1/2 French Canadian founder mutationDiala Abd-Rabbo, Christine Abaji, Guillaume B Cardin, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
Molecular, metabolic and functional CD4 T cell paralysis impedes tumor controlMengdi Guo, Diala Abd-Rabbo, Bruna Bertol, et al.
Cell Reports|August 31, 2023
Molecular, metabolic, and functional CD4 T cell paralysis in the lymph node impedes tumor controlMengdi Guo, Diala Abd-Rabbo, Bruna C Bertol, et al.
Nature Immunology|November 19, 2021
Dynamic CD4<sup>+</sup> T cell heterogeneity defines subset-specific suppression and PD-L1-blockade-driven functional restoration in chronic infectionLaura M Snell, Wenxi Xu, Diala Abd-Rabbo, et al.
Nature Communications|November 21, 2025
Topoisomerase IIb binding delineates localized mutational processes and driver mutations in cancer genomesLiis Uusküla-Reimand, Christian A Lee, Robin H Oh, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2024
A Unified Atlas of T cell GlycophysiologyFauzia N Izzati, Hani Choksi, Paolo Giuliana, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2026
Sequential infection reprograms the immune landscape to shape future responsesMengdi Guo, Yanis Hichem Bouzaher, Diala Abd-Rabbo, et al.
Immunity|November 12, 2022
The transcription factor IRF2 drives interferon-mediated CD8<sup>+</sup> T cell exhaustion to restrict anti-tumor immunitySabelo Lukhele, Diala Abd Rabbo, Mengdi Guo, et al.
Cell Reports|July 3, 2025
Presentation of immunoregulatory sialoglycans on T cells is divergent between mice and humansFauzia N Izzati, Hani Choksi, Paolo Giuliana, et al.
Molecular Cell|January 19, 2020
Candidate Cancer Driver Mutations in Distal Regulatory Elements and Long-Range Chromatin Interaction NetworksHelen Zhu, Liis Uusküla-Reimand, Keren Isaev, et al.
Pageof 3